LUNG
Pulmonx Corp. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website ulmonx.com
- Employees(FY) 269
- ISIN US7458481014
Performance
+2.86%
1W
+21.29%
1M
-37.15%
3M
-16.97%
6M
-29.41%
YTD
-28.06%
1Y
Profile
Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.
Investment Analysis Report: LUNG
Overview:
LUNG is a company operating in the Health Technology sector, specifically in the Medical Specialties industry. The company has a market capitalization of $548,572,178. In this report, we will conduct a detailed analysis of LUNG's financial statements over the past three years, focusing on the Balance Sh...
Technical Analysis of LUNG 2024-05-10
Overview:
In analyzing the technical indicators for LUNG stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide yo...
Recent News & Updates
- 2024-05-06 05:03
- 2024-05-05 21:55
- 2024-05-02 21:43
- 2024-05-02 21:43
- 2024-05-01 19:37
- 2024-05-01 19:05
Q1 2024 Pulmonx Corp Earnings Call(Yahoo Finance)
- 2024-05-01 15:38
- 2024-05-01 08:55
- 2024-05-01 06:05
- 2024-05-01 05:46
- 2024-05-01 04:05
Pulmonx Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-10 04:05
- 2024-04-02 04:05
- 2024-03-15 05:00
- 2024-02-29 10:35
- 2024-02-25 19:00
- 2024-02-23 06:20
Pulmonx Full Year 2023 Earnings: Beats Expectations(Simply Wall St.)
- 2024-02-22 09:55
- 2024-02-22 06:56
Q4 2023 Pulmonx Corp Earnings Call(Thomson Reuters StreetEvents)
- 2024-02-21 20:55
- 2024-02-21 16:44
- 2024-02-21 16:06
- 2024-02-21 16:05
- 2024-02-21 03:06
- 2024-02-21 03:05
- 2024-02-17 00:08
- 2024-02-13 13:08
PRIMECAP Management Bolsters Position in Pulmonx Corp(GuruFocus.com)
- 2024-02-07 16:05
- 2024-02-07 03:05
- 2023-12-22 23:19
Page 1 of 5
previousnext